Clinical trial
A Study of Risperidone Monotherapy in Bipolar Anxiety
NCT00167479 · University of South Florida, Other · Completed
Key facts
| NCT number | NCT00167479 |
|---|---|
| Title | A Study of Risperidone Monotherapy in Bipolar Anxiety |
| Official title | A Randomized, Double-Blind, Placebo-Controlled Study of Risperidone Monotherapy in Ambulatory Bipolar Disorder With Current at Least Moderately Severe Anxiety and Lifetime Panic Disorder or Generalized Anxiety Disorder |
| Lead sponsor | University of South Florida, Other |
| Collaborators | Janssen, LP Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Bipolar Disorder, Panic Disorder, Generalized Anxiety Disorder |
| Intervention type | Drug |
| Interventions | risperidone (Risperdal) |
| Enrollment | 60 |
| Start date | Sep 1, 2003 |
| Completion | Sep 1, 2006 |
| First posted | Sep 14, 2005 |
| Last update posted | Sep 11, 2006 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: